Trending Topics

Study suggests possible link between semaglutide and increased risk of NAION

There is a potential association between the use of semaglutide, a glucagon-like peptide 1 receptor agonist (GLP-1 RA) commonly prescribed for type 2 diabetes and weight loss, and an increased risk of nonarteritic anterior ischemic optic neuropathy (NAION), according to a study. Researchers conducted a retrospective matched cohort study using...